FIRST EPISODE PSYCHOSIS (FEP)
Clinical trials for FIRST EPISODE PSYCHOSIS (FEP) explained in plain language.
Never miss a new study
Get alerted when new FIRST EPISODE PSYCHOSIS (FEP) trials appear
Sign up with your email to follow new studies for FIRST EPISODE PSYCHOSIS (FEP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pumping iron to slow aging: new study targets psychosis patients
Disease control Not yet recruitingThis study looks at whether a 12-week strength training program can help slow down premature aging in 40 young adults (ages 18-35) who have had a first episode of psychosis. Researchers will measure telomere length (a marker of cellular aging) and other health indicators. The goa…
Matched conditions: FIRST EPISODE PSYCHOSIS (FEP)
Phase: NA • Sponsor: University of Salamanca • Aim: Disease control
Last updated May 17, 2026 06:19 UTC
-
New therapy aims to cut cannabis use in psychosis patients
Disease control Not yet recruitingThis study tests a therapy program called the Cannabis Clinic for Psychosis (CCP) to help people with first-episode psychosis reduce or stop using cannabis. About 80 adults who are dependent on cannabis and want to cut back will either receive the 12-session CCP therapy right awa…
Matched conditions: FIRST EPISODE PSYCHOSIS (FEP)
Phase: NA • Sponsor: King's College London • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Nasal insulin may unlock brain secrets in psychosis
Knowledge-focused Not yet recruitingThis study looks at how insulin given through the nose changes brain signals in people having their first episode of psychosis compared to healthy volunteers. Researchers will use brain scans to measure dopamine activity and energy-related chemicals. The goal is to understand the…
Matched conditions: FIRST EPISODE PSYCHOSIS (FEP)
Phase: NA • Sponsor: Medical University of Vienna • Aim: Knowledge-focused
Last updated May 17, 2026 06:20 UTC